FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,191,841 | +17.2% | 1,619,784 | -12.9% | 0.00% | 0.0% |
| Q2 2023 | $6,134,499 | +266.7% | 1,858,939 | +216.7% | 0.00% | – |
| Q1 2023 | $1,673,118 | -80.2% | 587,059 | -49.5% | 0.00% | -100.0% |
| Q4 2022 | $8,456,768 | +5.7% | 1,161,644 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $7,999,000 | +192.7% | 988,632 | +77.3% | 0.00% | +100.0% |
| Q2 2022 | $2,733,000 | -37.8% | 557,747 | +200.2% | 0.00% | 0.0% |
| Q1 2022 | $4,395,000 | +19.8% | 185,803 | -10.4% | 0.00% | 0.0% |
| Q4 2021 | $3,668,000 | -63.3% | 207,361 | -41.5% | 0.00% | -50.0% |
| Q3 2021 | $10,007,000 | +132.6% | 354,710 | -13.6% | 0.00% | +100.0% |
| Q2 2021 | $4,302,000 | – | 410,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |